• [Corrigendum] Melanogenesis in uveal melanoma cells: Effect of argan oil
• <em>In Situ</em> Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy
• A Case of Metastatic Uveal Melanoma: From Diagnosis to Survival Four Years Later
• A distorted pupil could be caused by an iris melanoma
• A Pilot Study to Evaluate the Usefulness of Optical Coherence Tomography for Staging Iris Pigmented Lesions in Cats
• A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)⁺/CD141 (BDCA-3)⁺ myeloid dendri
• A systematic review with evidence mapping of supportive care interventions for melanoma patients and caregivers
• Ambient ultraviolet radiation and ocular melanoma incidence in the United States, 2000-2019
• An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
• An optimized 3T MRI scan protocol to assess iris melanoma with subsequent histopathological verification - A prospective study
• An unusual case of a pigment epithelial cyst masquerading as a uveal melanoma after zoster ophthalmicus-related iris atrophy
• Angiographic Features of Iris Melanocytic Tumors: Nevus versus Melanoma
• Anterior plaque brachytherapy placement for treatment of iris and iridociliary melanomas - Surgical procedure and institutional experience
• Anterior segment swept-source optical coherence tomography and ultrasound biomicroscopy in iris and ciliary body lesions
• Anterior Uveal Melanocytoma: Role of Diagnostic FNAB
• Asymmetric preservation of choroidal pigmentation simulating choroidal nevus in two siblings with Waardenburg syndrome type 2A
• Automated Detection of Pigmented Iris Freckles Using a Deep Neural Network for Cutaneous Melanoma Risk
• Benign and Malignant Iris Tumors
• CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells
• Characteristics of amelanotic iris lesions - a ten-year historical cohort
• Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
• Choroidal melanoma tumor profile and treatment pattern for newly diagnosed patients at a reference public hospital in Sao Paulo, Brazil
• Chronic angle closure glaucoma with an atypical iris-pupillary membrane
• Clinical characteristics and postoperative complications as predictors of radiation toxicity after treatment with I125 Eye Plaque Brachytherapy for Uveal Melanomas
• Clinical descriptive and long-term outcome of melanocytic uveal lesions in young dogs: 40 cases (45 eyes) including 13 cases of sector iridectomy
• Clinical Outcomes in AYAs (Adolescents and Young Adults) Treated with Proton Therapy for Uveal Melanoma: A Comparative Matching Study with Elder Adults
• Clustering of uveal melanoma: County wide analysis within Ohio
• Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death
• Correlation of fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma
• Cysts and tumours of the iris: Diagnostic tools and key management considerations-A review
• Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade
• Delayed recurrence of an iridociliary malignant melanoma 180 from the primary tumor
• Delayed recurrence of an iridociliary malignant melanoma 180° from the primary tumor
• Diode laser ablation of progressive pigmented iris lesions in 317 cats (356 eyes) appears overall safe and effective in decreasing progression of iris pigmentation
• Edge Creep: Increased Pigmentation at the Border of Choroidal Melanomas Treated with Plaque Brachytherapy
• Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approaches
• Elevated intraocular pressure as presenting sign of iris ring melanoma
• Extensive intraocular melanoma with secondary glaucoma in a 15-month-old Thoroughbred filly
• Eye Melanoma Diagnosis System using Statistical Texture Feature Extraction and Soft Computing Techniques
• First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance
• Focal reactive nodular gliosis: an extremely rare retinal astrocytic tumor
• Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
• High-Dose-Rate Yttrium-90 ((90)Y) Episcleral Plaque Brachytherapy for Iris and Iridociliary Melanoma
• Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology center
• In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy
• Influence of Post-radiation Ocular Surface Disorder on Ocular Surgery: A Case Report and Review of the Literature
• Intraocular Lens and Lens Capsule Spread of Iridociliary Melanoma: Clinical and Histopathologic Features of 2 Cases
• Intraocular tumours imaging with transpalpebral near-infrared LED transillumination: Pilot study
• Iridociliary metastasis from cryptic cutaneous melanoma simulating primary uveal melanoma
• Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations
• Iris Cyst
• Iris melanoma in an Australian cohort
• Iris melanoma outcomes based on the Cancer Genome Atlas (TCGA) classification in 78 consecutive patients
• Iris melanoma versus syphilitic iris nodule: A diagnostic challenge
• Iris melanoma: Prognostication for metastasis
• Iris Melanoma: Review of Clinical Features, Risks, Management and Outcomes
• Iris melanoma: Review of clinical features, risks, management, and outcomes
• Iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma
• Iris pattern as a marker of skin cancer risk
• Iris Pigmented Lesions and Risk of Cutaneous Melanoma: Case-Control Study in Lithuania
• Iris Ring Melanoma Presenting as Scleral Pigmentation
• Lisch nodules: an ophthalmic marker of neurofibromatosis type 1
• Local Resection in Choroidal Melanoma: A Review
• Locally advanced choroidal melanoma with favorable molecular prognosis - case report
• Long-term course with iris changes after trabeculectomy for uveitic glaucoma associated with iris mammillation: a case report
• Malignant Epiretinal Membrane After Proton Beam Radiation of Ciliary Body Melanoma
• Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline
• MELANOCYTIC NEOPLASIA IN <em>PANTHERA</em> SPECIES: CLINICAL PRESENTATIONS, PATHOLOGIC FINDINGS AND RESPONSES TO TREATMENT
• Metastatic extradural melanoma of the lumbar spine in a cat
• MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression
• Multifocal choroidal melanoma: a clinicohistopathological correlation
• Multimodal Imaging in Iris Vascular Tumors: A Case Series
• Multiple Iris Nevi in an Eye With Ciliochoroidal Melanoma
• Next-generation sequencing of a large uveal melanoma with whole genome doubling and a <em>PBRM1</em> mutation
• Next-generation sequencing of a large uveal melanoma with whole genome doubling and a PBRM1 mutation
• Ocular Melanoma
• Outcome of combined cataract surgery and iris prosthesis implantation in iris melanoma patients previously treated with iridocyclectomy: A national retrospective non-comparative case series
• Pathological findings in enucleated eyes of patients with neurofibromatosis type 1: report of a case with 15-year follow-up and review of 14 patients in the literature
• Pediatric ocular melanoma: a collaborative multicenter study and meta-analysis
• Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2)
• Predictive model for iris melanoma
• Prevalence of and Associated Factors for Eyelid Cancer in the American Academy of Ophthalmology Intelligent Research in Sight Registry
• Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes
• Recent Advances in Characterization of Melanin Pigments in Biological Samples
• Relationship between Fitzpatrick Skin Type and The Cancer Genome Atlas Classification with Melanoma-Related Metastasis and Death in 854 Patients at a Single Ocular Oncology Center
• Ruthenium brachytherapy for iris melanoma
• Secondary glaucoma: Toward interventions based on molecular underpinnings
• Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma
• Small EV-based delivery of CpG ODNs for melanoma postsurgical immunotherapy
• SOX-10 and TRP-1 expression in feline ocular and nonocular melanomas
• Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma
• The multifunctional human ocular melanocortin system
• Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series
• Unilateral acute iris transillumination syndrome with glaucoma and iris pigment epithelium dispersion simulating iris melanoma
• Unusual Tumours Hidden in Blind Eyes
• Using Electronic Health Record Data to Determine the Safety of Aqueous Humor Liquid Biopsies for Molecular Analyses
• Uveal Melanoma and the IRIS Registry (Intelligent Research in Sight): A Pilot Analysis and Future Directions
• Uveal Melanoma and the IRIS® Registry (Intelligent Research in Sight): A Pilot Analysis and Future Directions
• Uveal melanoma in the Iranian population: two decades of patient management in a tertiary eye center
• Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors